Strata Oncology Revenue and Competitors

Detroit, MI USA

Location

$128M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Strata Oncology's estimated annual revenue is currently $15.5M per year.(i)
  • Strata Oncology's estimated revenue per employee is $155,000
  • Strata Oncology's total funding is $128M.

Employee Data

  • Strata Oncology has 100 Employees.(i)
  • Strata Oncology grew their employee count by -4% last year.

Strata Oncology's People

NameTitleEmail/Phone
1
Co-founder & CEOReveal Email/Phone
2
Chief Data ScientistReveal Email/Phone
3
CFOReveal Email/Phone
4
Chief Business Development Officer & Chief Compliance and Legal OfficerReveal Email/Phone
5
SVP Clinical DevelopmentReveal Email/Phone
6
VP Product ManagementReveal Email/Phone
7
ControllerReveal Email/Phone
8
SVP Clinical PartnershipsReveal Email/Phone
9
VP, Laboratory OperationsReveal Email/Phone
10
VP Customer SuccessReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.9M120%N/AN/A
#2
$2.6M34-56%$31.2MN/A
#3
$0.8M5-44%N/AN/A
#4
$1.9M24100%N/AN/A
#5
$6M39-11%N/AN/A
#6
$4M26-33%N/AN/A
#7
$1.9M120%N/AN/A
#8
$0.8M525%N/AN/A
#9
$14.6M948%N/AN/A
#10
$3.4M225%N/AN/A
Add Company

What Is Strata Oncology?

Strata Oncology is a high-growth, state-of-the art, precision oncology company, delivering a new standard of care that integrates molecular profiling, decision support and clinical trial participation into routine practice. We do this by partnering with major healthcare systems across the country, who systematically send their cancer patients? biopsies to our high-throughput CLIA lab for genomic sequencing, with results provided to the oncologist within days, indicating the tumor profile, and matches to appropriate therapies and drug trials. This accelerates the move to personalized medicine ? right medicines to the right patients at the right time. Our personnel are passionate about and committed to making a positive difference, now, in the lives of cancer patients and their families. Clinicians, pathologists, bioinformaticists, software engineers, lab technicians and more, coming together to give access to those without, uncovering insight that might be hidden, all while spreading urgency to all. In just two years we have established a nationwide network of leading health system partners, scaled a high-throughput NGS laboratory, and importantly have started to provide actionable insight to the lives of cancer patients. It?s been a good start. Join us, as the Team doubles in size over the next year from its current base of 30. Experience a career that connects a fast-paced team environment with a worthy pursuit ? feel good about what you?ve accomplished at the end of every day!

keywords:Biotechnology, Pharmaceuticals, Genetic Testing, Genomics

$128M

Total Funding

100

Number of Employees

$15.5M

Revenue (est)

-4%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Strata Oncology News

2022-04-13 - In Brief This Week: Blueprint Medicines, AstraZeneca, Kite, Zai ...

... genomic profiling (CGP) for advanced cancer patients. ... Invitae, Roche, Thermo Fisher Scientific, Strata Oncology, Tempus, Illumina,...

2022-03-22 - Strata Oncology Sentinel Trial for Personalized Cancer ...

Strata Oncology, Inc. is a precision oncology company dedicated to delivering the best possible treatment for each patient with cancer. The...

2022-03-22 - Strata Oncology Named to Fast Company's Annual List of the ...

Strata Oncology, Inc. is a precision oncology company dedicated to delivering the best possible treatment for each patient with cancer. The...

2021-09-08 - Strata Oncology Announces Publication of Analytical and Clinical Validation of StrataNGS® in the Journal of Molecular Diagnostics

ANN ARBOR, Mich., Sept. 8, 2021 /PRNewswire/ -- Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced results from validation studies demonstrating the reliable performance of the StrataNGS test were published in The Journal o ...

2021-08-23 - New Publication Demonstrates Ability of StrataNGS® to Expand Proportion of Testable Tumor Tissue Samples for Precision Medicine

ANN ARBOR, Mich., Aug. 23, 2021 /PRNewswire/ -- Strata Oncology, Inc., a precision oncology company advancing molecular indications for cancer therapies, today announced the publication of a new peer-reviewed study in which more than double the number of tumor tissue samples met minimum tumor ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$14.5M100N/AN/A
#2
$23.9M1009%N/A
#3
$31.1M1019%N/A
#4
$7.5M10129%N/A
#5
$27.7M101-2%$12.8M